Fierce Pharma

OCTOBER 21, 2024

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too. | As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too.

Patients 144

Patients 144

MedCity News

OCTOBER 21, 2024

Within a matter of months, we’re likely to see substantial growth in the number of EP ablation procedures performed in surgery centers outside the hospital. Here’s what we can expect. The post How the Move of Ablation Procedures into Surgery Centers Will Transform Electrophysiology appeared first on MedCity News.

64

64

Fierce Pharma

OCTOBER 21, 2024

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights. | Starboard, which recently pitched turnaround plans to Pfizer, reportedly thinks the J&J consumer health spinout's stocks have underperformed since its market debut over a year ago.

Marketing 130

Marketing 130

MedCity News

OCTOBER 21, 2024

The FDA approved Astellas’s Vyloy as a treatment for advanced cases of gastric or gastroesophageal junction (GEJ) adenocarcinoma positive for a protein called claudin 18.2. It’s the first FDA-approved therapy for this target. The post Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer appeared first on MedCity News.

Pharma 60

Pharma FDA Biopharma 60

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

OCTOBER 21, 2024

Sanofi is now in “exclusive negotiations” with U.S. | Sanofi is now in “exclusive negotiations" with U.S. private equity firm Clayton, Dubilier & Rice to sell a 50% controlling stake in its consumer health business Opella, the company said. The deal values the consumer group at 16 billion euros.

130

130

pharmaphorum

OCTOBER 21, 2024

A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for the drug.Vabysmo (faricimab) has been approved by the FDA for treating DME since 2022, quickly becoming one of the Swiss pharma group's fastest-growing products with sales of $1.1 billion in the first half of the year.

FDA 60

FDA Sales Pharma Patients 60

MedCity News

OCTOBER 21, 2024

Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches. The post The Funding Model for Cancer Innovation is Broken — We Can Fix It appeared first on MedCity News.

Medical 60

Medical 60

Fierce Pharma

OCTOBER 21, 2024

Following a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. | As part of a new round of layoffs, certain Takeda staffers at two Massachusetts sites are set to lose their jobs. This marks the third round of job cuts Takeda has initiated in the state since it revealed a large restructuring drive in May.

130

130

Pharmaceutical Commerce

OCTOBER 21, 2024

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, explains the top mistakes healthcare organizations make when building and maintaining their software.

Pharma 59

Pharma Healthcare Healthcare 59

PharmaVoice

OCTOBER 21, 2024

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

FDA 59

FDA 59

Advertisement

PharmaTech

OCTOBER 21, 2024

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, spoke on recent challenges and trends in softgel formulations.

Pharma 52

Pharma 52

PharmExec

OCTOBER 21, 2024

In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.

Patients 52

Patients Education Pharmaceutical 52

pharmaphorum

OCTOBER 21, 2024

In a new webinar with Atlas Clinical Research’s Chief Executive Officer Mark Scullion and Terttu Haring, President of Sites & Patients at Syneos Health and former investigator, learn more about the site experience for clinical research sites – including the important need for a partner who understands the challenges and drives solutions that can ease burden, create a better experience, and expand access and representation in clinical research for patients.

Patients 52

Patients 52

PharmaTech

OCTOBER 21, 2024

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights of his talk at AAPS PharmSci 360.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

PharmExec

OCTOBER 21, 2024

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how personalized audio will be utilized within the pharma marketing industry in 2025.

Marketing 52

Marketing Pharma Pharmaceutical 52

pharmaphorum

OCTOBER 21, 2024

Two digital therapeutics for addiction are available again through PursueCare, which acquired them from now-defunct Pear Tx last year

60

60

PharmaVoice

OCTOBER 21, 2024

Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.

Patients 52

Patients 52

pharmaphorum

OCTOBER 21, 2024

Novo Nordisk's TFPI drug concizumab has been backed for approval in the EU to prevent bleeding episodes in people with haemophilia and inhibitors

56

56

Advertisement

Distribution

Pharmaceutical Technology

OCTOBER 21, 2024

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies.

Manufacturing 59

Manufacturing 59

PharmExec

OCTOBER 21, 2024

Vylov is the first CLDN18.2-targeted therapy for advanced gastric and gastroesophageal junction adenocarcinoma to be approved in the United States.

FDA 52

FDA 52

Pharmaceutical Technology

OCTOBER 21, 2024

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of Sanofi’s consumer health business.

Government 52

Government Sales 52

PharmExec

OCTOBER 21, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

OCTOBER 21, 2024

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.

FDA 52

FDA Pharma 52

PharmExec

OCTOBER 21, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Pharmaceutical Technology

OCTOBER 21, 2024

Arcutis Canada, has received Health Canada's approval for ZORYVE to treat seborrheic dermatitis in patients aged nine years and above.

Patients 52

Patients 52

PharmExec

OCTOBER 21, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Pharmaceutical Technology

OCTOBER 21, 2024

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis pigmentosa (RP).

Patients 52

Patients 52

PharmExec

OCTOBER 21, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Patients 52

Patients 52

Pharmaceutical Technology

OCTOBER 21, 2024

The funding will support Seaport’s technology platform, which helps drugs be absorbed more efficiently through the lymphatic system.

52

52

PharmaTimes

OCTOBER 21, 2024

The five new programmes are designed to fit alongside full-time work and clinical practice

Healthcare 59

Healthcare Healthcare Education Medical 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety